These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism. Hassa H; Tanir HM; Yildiz Z Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383 [TBL] [Abstract][Full Text] [Related]
7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102 [TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965 [TBL] [Abstract][Full Text] [Related]
9. Polycystic ovarian syndrome. Trikudanathan S Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652 [TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities. Elkind-Hirsch KE Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059 [TBL] [Abstract][Full Text] [Related]
11. Changes in the PCOS phenotype with age. Hsu MI Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of polycystic ovary syndrome: a practical guide. Stankiewicz M; Norman R Drugs; 2006; 66(7):903-12. PubMed ID: 16740005 [TBL] [Abstract][Full Text] [Related]
14. PCOS in adolescence and type 2 diabetes. Carreau AM; Baillargeon JP Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203 [TBL] [Abstract][Full Text] [Related]
15. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728 [TBL] [Abstract][Full Text] [Related]
16. Clinical Implications of Polycystic Ovary Syndrome in Adolescents. Hachey LM; Kroger-Jarvis M; Pavlik-Maus T; Leach R Nurs Womens Health; 2020 Apr; 24(2):115-126. PubMed ID: 32273076 [TBL] [Abstract][Full Text] [Related]
17. Mild androgen phenotypes. Carmina E Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):207-20. PubMed ID: 16772152 [TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome in the Indian Subcontinent. Allahbadia GN; Merchant R Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079 [TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome and mitochondrial dysfunction. Zhang J; Bao Y; Zhou X; Zheng L Reprod Biol Endocrinol; 2019 Aug; 17(1):67. PubMed ID: 31420039 [TBL] [Abstract][Full Text] [Related]